138 related articles for article (PubMed ID: 7381208)
1. Chemotactically responsive and nonresposive forms of a continuous human monocyte cell line.
Fischer DG; Pike MC; Koren HS; Snyderman R
J Immunol; 1980 Jul; 125(1):463-5. PubMed ID: 7381208
[No Abstract] [Full Text] [Related]
2. Chemotactic deactivation of human neutrophils: relationship to loss of cytotaxin receptor function and temporal nature of the phenomenon.
Nelson RD; Fiegel VD; Herron MJ; Simmons RL
J Reticuloendothel Soc; 1980 Sep; 28(3):285-94. PubMed ID: 7411541
[No Abstract] [Full Text] [Related]
3. Human monocyte chemotaxis in vitro. Influence of in vitro variables in the filter assay.
Nielsen H; Olesen Larsen S
Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):109-15. PubMed ID: 6349251
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures.
Fearon DT; Collins LA
J Immunol; 1983 Jan; 130(1):370-5. PubMed ID: 6847888
[No Abstract] [Full Text] [Related]
5. Inhibitors of monocyte responses to chemotaxins are associated with human neoplasms.
Snyderman R; Cianciolo G
Adv Exp Med Biol; 1982; 155():343-52. PubMed ID: 7158488
[No Abstract] [Full Text] [Related]
6. Stimulation of granulocyte adhesiveness by the chemotactic peptide N-formyl-L-methionyl-L-phenylalanine.
Patrone F; Dallegri F; Sacchetti C
Res Exp Med (Berl); 1980; 177(1):19-22. PubMed ID: 7403684
[TBL] [Abstract][Full Text] [Related]
7. Antagonists of the formylated peptide chemoattractants: structure-activity comparisons with formyl-methionyl-leucyl-phenylalanine-OH.
Freer RJ; Day AR; Muthukumaraswamy N; Showell HJ; Becker EL
Kroc Found Ser; 1981; 14():161-8. PubMed ID: 6947071
[No Abstract] [Full Text] [Related]
8. Development of specific receptors for N-formylated chemotactic peptides in a human monocyte cell line stimulated with lymphokines.
Pike MC; Fischer DG; Koren HS; Snyderman R
J Exp Med; 1980 Jul; 152(1):31-40. PubMed ID: 7400755
[TBL] [Abstract][Full Text] [Related]
9. Regulation of human polymorphonuclear leukocyte superoxide release by cellular responses to chemotactic peptides.
English D; Roloff JS; Lukens JN
J Immunol; 1981 Jan; 126(1):165-71. PubMed ID: 6256437
[No Abstract] [Full Text] [Related]
10. Selective inhibition of human neutrophilic chemotaxis by echo virus, type 9. Virus-induced changes in membrane fluidity.
Bültmann B; Melzner I; Haferkamp O; Gruler H
Pathol Res Pract; 1982; 175(2-3):308-11. PubMed ID: 7182838
[TBL] [Abstract][Full Text] [Related]
11. Leucoattractants enhance complement receptors on human phagocytic cells.
Kay AB; Glass EJ; Salter DM
Clin Exp Immunol; 1979 Nov; 38(2):294-9. PubMed ID: 527263
[TBL] [Abstract][Full Text] [Related]
12. Monocyte aggregation and superoxide anion release in response to formyl-methionyl-leucyl-phenylalanine (FMLP) and platelet-activating factor (PAF).
Yasaka T; Boxer LA; Baehner RL
J Immunol; 1982 May; 128(5):1939-44. PubMed ID: 6278021
[TBL] [Abstract][Full Text] [Related]
13. Chemotaxis in vitreous haemorrhage: an experimental study.
LaNauze JH; Hembry RM; Jacobson W; Watson PG
Exp Eye Res; 1982 May; 34(5):803-13. PubMed ID: 7084341
[No Abstract] [Full Text] [Related]
14. The influence of chemotactic factors on the expression of phagocyte receptors.
Glass EJ; Stewart J; Weir DM
J Clin Lab Immunol; 1982 Jan; 7(1):39-41. PubMed ID: 7069777
[No Abstract] [Full Text] [Related]
15. Cyclic nucleotides regulate the morphologic alterations required for chemotaxis in monocytes.
Stephens CG; Snyderman R
J Immunol; 1982 Mar; 128(3):1192-7. PubMed ID: 6120193
[TBL] [Abstract][Full Text] [Related]
16. [Acylated tripeptides as chemotaxin antagonists (author's transl)].
Opitz W; Fruchtmann R
Hoppe Seylers Z Physiol Chem; 1981 Aug; 362(8):1037-41. PubMed ID: 7346374
[TBL] [Abstract][Full Text] [Related]
17. Chemotactic factor-induced polarization, receptor redistribution, and locomotion of human blood monocytes.
Islam LN; Wilkinson PC
Immunology; 1988 Jul; 64(3):501-7. PubMed ID: 3410494
[TBL] [Abstract][Full Text] [Related]
18. The effect of cytochalasin A on polymorphonuclear leukocytes activated by chemotactic peptide.
Elferink JG; Riemersma JC
J Reticuloendothel Soc; 1981 Feb; 29(2):163-71. PubMed ID: 6260942
[No Abstract] [Full Text] [Related]
19. Specificity and reversibility of chemotactic deactivation of human monocytes.
Falk W; Leonard EJ
Infect Immun; 1981 May; 32(2):464-8. PubMed ID: 6265358
[TBL] [Abstract][Full Text] [Related]
20. Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist.
Dahinden C; Fehr J
J Clin Invest; 1980 Nov; 66(5):884-91. PubMed ID: 7430350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
